Showing results (21-30 of 30) with videos related to
Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 30 results.
Diabetes & Vascular Disease Research|May 19, 2016
Early myocardial impairment in type 1 diabetes patients without known heart disease assessed with tissue Doppler echocardiography: The Thousand & 1 studyMagnus Thorsten Jensen, Peter Sogaard, Henrik Ullits Andersen, et al.Journal of Research in Pharmacy Practice|May 19, 2015
Identification of possible adverse drug reactions in clinical notes: The case of glucose-lowering medicinesPernille Warrer, Peter Bjødstrup Jensen, Lise Aagaard, et al.Frontiers in Endocrinology|April 30, 2019
Liraglutide-Induced Weight Loss May be Affected by Autonomic Regulation in Type 1 DiabetesChristian Stevns Hansen, Christian Seerup Frandsen, Jesper Fleischer, et al.JACC. Cardiovascular Imaging|March 10, 2015
Global longitudinal strain is not impaired in type 1 diabetes patients without albuminuria: the Thousand & 1 studyMagnus Thorsten Jensen, Peter Sogaard, Henrik Ullits Andersen, et al.The Lancet. Diabetes & Endocrinology|December 15, 2015
Efficacy and safety of liraglutide for overweight adult patients with type 1 diabetes and insufficient glycaemic control (Lira-1): a randomised, double-blind, placebo-controlled trialThomas Fremming Dejgaard, Christian Seerup Frandsen, Tanja Stenbæk Hansen, et al.BMC Endocrine Disorders|July 25, 2019
The effect of insulin degludec on risk of symptomatic nocturnal hypoglycaemia in adults with type 1 diabetes and high risk of nocturnal severe hypoglycaemia (the HypoDeg trial): study rationale and designRikke Mette Agesen, Amra Ciric Alibegovic, Henrik Ullits Andersen, et al.Journal of Diabetes Science and Technology|September 6, 2023
The Effect of Insulin Degludec Versus Insulin Glargine U100 on Glucose Metrics Recorded During Continuous Glucose Monitoring in People With Type 1 Diabetes and Recurrent Nocturnal Severe HypoglycemiaJulie Maria Bøggild Brøsen, Rikke Mette Agesen, Amra Ciric Alibegovic, et al.Diabetes Technology & Therapeutics|April 25, 2022
Continuous Glucose Monitoring-Recorded Hypoglycemia with Insulin Degludec or Insulin Glargine U100 in People with Type 1 Diabetes Prone to Nocturnal Severe HypoglycemiaJulie Maria Bøggild Brøsen, Rikke Mette Agesen, Amra Ciric Alibegovic, et al.Diabetes, Obesity & Metabolism|February 7, 2023
Effect of insulin degludec versus insulin glargine U100 on nocturnal glycaemia assessed by plasma glucose profiles in people with type 1 diabetes prone to nocturnal severe hypoglycaemiaJulie Maria Bøggild Brøsen, Rikke Mette Agesen, Peter Lommer Kristensen, et al.Elife|December 11, 2019
Linking glycemic dysregulation in diabetes to symptoms, comorbidities, and genetics through EHR data miningIsa Kristina Kirk, Christian Simon, Karina Banasik, et al.Pageof 3